 |
Gladstone Place Partners is handling the $1.2B three-way business combination of Obagi advanced skin care company, Milk Makeup vegan brand and Waldencast Acquisition Corp. SPAC to create a global beauty and wellness platform.
Obagi is a leading player in the fast-growing dermo-cosmetic space, ranking as the No. 1 doctor-dispensed brand for treating acne, premature aging, sun damage and discoloration.
Milk Makeup markets more than 300 cruelty-free, vegan and clean formula products that are sold in Sephora and other retail outlets.
Waldencast is led by CEO Michel Brousset, who was group president of L’Oreal North America consumer products, and COO Hind Sebti, a veteran of L’Oreal and Procter & Gamble.
Brousset said, “partnering with Obagi and Milk Makeup is a major milestone in our ambition to build a best-in-class global multi-brand beauty platform, which will be home for the next generation of high-growth, purpose-driven brands.”
Gladstone Place Partners’ Steve Lipin and Christina Stenson represent Waldencast.
Joele Frank handles Crinetics Pharmaceuticals as the specialist for treatments for endocrine diseases agrees to get acquired by Vertex Pharmaceuticals in a deal pegged at $8.8B.
Teneo represents Honeywell spin-off Solstice Advanced Materials as it buys Collected Strategies client Element Solutions in a deal pegged at $14.5B.
Dallas-based Throughline Global Advisors advised Principal Mineral as it acquired Isola Group, maker of copper-clad laminates used in printed circuit boards.
oele Frank works for satellite operator Iridium Communications as it gets acquired by space company Rocket Lab in a deal worth $8B.
Uber’s Mike Lucarelli is moving to NXP Semiconductors as senior VP-investor relations.
